{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:10:26Z","timestamp":1790662226754,"version":"4.1.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["N01HV68161"],"award-info":[{"award-number":["N01HV68161"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["N01HV68162"],"award-info":[{"award-number":["N01HV68162"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["N01HV68163"],"award-info":[{"award-number":["N01HV68163"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["N01HV68164"],"award-info":[{"award-number":["N01HV68164"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["U01HL64829"],"award-info":[{"award-number":["U01HL64829"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["U01HL64914"],"award-info":[{"award-number":["U01HL64914"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["U01HL64924"],"award-info":[{"award-number":["U01HL64924"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K23HL105787"],"award-info":[{"award-number":["K23HL105787"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K23 HL125941"],"award-info":[{"award-number":["K23 HL125941"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K23HL127262"],"award-info":[{"award-number":["K23HL127262"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K23HL151867"],"award-info":[{"award-number":["K23HL151867"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["T32HL69751"],"award-info":[{"award-number":["T32HL69751"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["T32HL116273"],"award-info":[{"award-number":["T32HL116273"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL090957"],"award-info":[{"award-number":["R01HL090957"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL033610"],"award-info":[{"award-number":["R01HL033610"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL056921"],"award-info":[{"award-number":["R01HL056921"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL146158"],"award-info":[{"award-number":["R01HL146158"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL146158-04S1"],"award-info":[{"award-number":["R01 HL146158-04S1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL153500"],"award-info":[{"award-number":["R01 HL153500"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["UM1HL087366"],"award-info":[{"award-number":["UM1HL087366"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03AG032631"],"award-info":[{"award-number":["R03AG032631"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U54AG065141"],"award-info":[{"award-number":["U54AG065141"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["M01RR000425"],"award-info":[{"award-number":["M01RR000425"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000064"],"award-info":[{"award-number":["UL1TR000064"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001427"],"award-info":[{"award-number":["UL1TR001427"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract\u00a0\u00a0\u00a0<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Abnormal structure and function of the coronary microvasculature have been implicated in the pathophysiology of multiple cardiovascular disease processes. This article reviews recent research progress related to coronary microvascular dysfunction (CMD) and salient clinical takeaways.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>CMD is prevalent in patients with signs and symptoms of ischemia and no obstructive epicardial coronary artery disease (INOCA), particularly in women. CMD is associated with adverse outcomes, including most frequently the development of heart failure with preserved ejection fraction. It is also associated with adverse outcomes in patient populations including hypertrophic cardiomyopathy, dilated cardiomyopathy, and acute coronary syndromes. In patients with INOCA, stratified medical therapy guided by invasive coronary function testing to define the subtype of CMD leads to improved symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>There are invasive and non-invasive methodologies to diagnose CMD that provide prognostic information and mechanistic information to direct treatment. Available treatments improve symptoms and myocardial blood flow; ongoing investigations aim to develop therapy to improve adverse outcomes related to CMD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11883-023-01116-z","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T07:03:03Z","timestamp":1687244583000},"page":"435-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know"],"prefix":"10.1007","volume":"25","author":[{"given":"Paul","family":"Marano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9933-5155","authenticated-orcid":false,"given":"C. Noel Bairey","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"issue":"8","key":"1116_CR1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830\u201340.","journal-title":"N Engl J Med"},{"issue":"4","key":"1116_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCRESAHA.121.319892","volume":"130","author":"HR Reynolds","year":"2022","unstructured":"Reynolds HR, Merz CNB, Berry C, et al. Coronary arterial function and disease in women with no obstructive coronary arteries. Circ Res. 2022;130(4):529\u201351.","journal-title":"Circ Res"},{"issue":"4 Pt 2","key":"1116_CR3","first-page":"H779","volume":"251","author":"WM Chilian","year":"1986","unstructured":"Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol. 1986;251(4 Pt 2):H779-788.","journal-title":"Am J Physiol"},{"issue":"4","key":"1116_CR4","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.yjmcc.2011.10.001","volume":"52","author":"A Deussen","year":"2012","unstructured":"Deussen A, Ohanyan V, Jannasch A, Yin L, Chilian W. Mechanisms of metabolic coronary flow regulation. J Mol Cell Cardiol. 2012;52(4):794\u2013801.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1116_CR5","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/01.CIR.92.3.518","volume":"92","author":"L Kuo","year":"1995","unstructured":"Kuo L, Davis MJ, Chilian WM. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary microcirculation. Circulation. 1995;92(3):518\u201325.","journal-title":"Circulation"},{"issue":"2","key":"1116_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/01.CIR.95.2.522","volume":"95","author":"WM Chilian","year":"1997","unstructured":"Chilian WM. Coronary microcirculation in health and disease. Circulation. 1997;95(2):522\u20138.","journal-title":"Circulation"},{"issue":"5","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1161\/ATVBAHA.121.316025","volume":"41","author":"S Godo","year":"2021","unstructured":"Godo S, Suda A, Takahashi J, Yasuda S, Shimokawa H. Coronary microvascular dysfunction. Arterioscler Thromb Vasc Biol. 2021;41(5):1625\u201337.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"1116_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0167-5273(94)90003-5","volume":"43","author":"H Suzuki","year":"1994","unstructured":"Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol. 1994;43(2):139\u201350.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/01.CIR.84.1.203","volume":"84","author":"M Mosseri","year":"1991","unstructured":"Mosseri M, Schaper J, Admon D, et al. Coronary capillaries in patients with congestive cardiomyopathy or angina pectoris with patent main coronary arteries. Ultrastructural morphometry of endomyocardial biopsy samples. Circulation. 1991;84(1):203\u201310.","journal-title":"Circulation"},{"issue":"1","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI116183","volume":"91","author":"K Egashira","year":"1993","unstructured":"Egashira K, Inou T, Hirooka Y, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Investig. 1993;91(1):29\u201337.","journal-title":"J Clin Investig"},{"issue":"4","key":"1116_CR11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1172\/JCI117852","volume":"95","author":"AA Quyyumi","year":"1995","unstructured":"Quyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Investig. 1995;95(4):1747\u201355.","journal-title":"J Clin Investig"},{"issue":"7","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","volume":"59","author":"P Ong","year":"2012","unstructured":"Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries: the ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59(7):655\u201362.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1116_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hfc.2015.08.012","volume":"12","author":"S Agrawal","year":"2016","unstructured":"Agrawal S, Mehta PK, Bairey Merz CN. Cardiac syndrome X: update. Heart Fail Clin. 2016;12(1):141\u201356.","journal-title":"Heart Fail Clin"},{"key":"1116_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","volume":"250","author":"P Ong","year":"2018","unstructured":"Ong P, Camici PG, Beltrame JF, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16\u201320.","journal-title":"Int J Cardiol"},{"issue":"33","key":"1116_CR15","first-page":"2565","volume":"38","author":"JF Beltrame","year":"2017","unstructured":"Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38(33):2565\u20138.","journal-title":"Eur Heart J"},{"issue":"3","key":"1116_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","volume":"27","author":"G Russo","year":"2013","unstructured":"Russo G, Di Franco A, Lamendola P, et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther. 2013;27(3):229\u201334.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"17","key":"1116_CR17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","volume":"35","author":"F Crea","year":"2013","unstructured":"Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2013;35(17):1101\u201311.","journal-title":"Eur Heart J"},{"issue":"21","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Carli MFD. Coronary microvascular disease pathogenic mechanisms and therapeutic options. J Am Coll Cardiol. 2018;72(21):2625\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"3 Suppl","key":"1116_CR19","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jacc.2004.12.084","volume":"47","author":"CN Bairey Merz","year":"2006","unstructured":"Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI-sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(3 Suppl):S21-29.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1116_CR20","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa0907272","volume":"362","author":"MR Patel","year":"2010","unstructured":"Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886\u201395.","journal-title":"N Engl J Med"},{"issue":"5","key":"1116_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1067\/mhj.2001.114198","volume":"141","author":"SE Reis","year":"2001","unstructured":"Reis SE, Holubkov R, Conrad Smith AJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J. 2001;141(5):735\u201341.","journal-title":"Am Heart J"},{"key":"1116_CR22","doi-asserted-by":"publisher","first-page":"7169275","DOI":"10.1155\/2019\/7169275","volume":"2019","author":"RD Anderson","year":"2019","unstructured":"Anderson RD, Petersen JW, Mehta PK, et al. Prevalence of coronary endothelial and microvascular dysfunction in women with symptoms of ischemia and no obstructive coronary artery disease is confirmed by a new cohort: the NHLBI-sponsored Women\u2019s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD). J Interv Cardiol. 2019;2019:7169275. This work confirmed a high rate of CMD in women with signs and symptoms of ischemia but without obstructive epicardial CAD.","journal-title":"J Interv Cardiol"},{"issue":"11","key":"1116_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","volume":"8","author":"JD Sara","year":"2015","unstructured":"Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv. 2015;8(11):1445\u201353.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"1116_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.114.012636","volume":"131","author":"BK Lee","year":"2015","unstructured":"Lee BK, Lim HS, Fearon WF, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131(12):1054\u201360.","journal-title":"Circulation"},{"issue":"6","key":"1116_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1540-8183.2010.00598.x","volume":"23","author":"MA Khuddus","year":"2010","unstructured":"Khuddus MA, Pepine CJ, Handberg EM, et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE). J Interv Cardiol. 2010;23(6):511\u20139.","journal-title":"J Interv Cardiol"},{"issue":"1","key":"1116_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0008-6363(97)00225-3","volume":"37","author":"P Moreau","year":"1998","unstructured":"Moreau P, d\u2019Uscio LV, L\u00fcscher TF. Structure and reactivity of small arteries in aging. Cardiovasc Res. 1998;37(1):247\u201353.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"1116_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00004872-200303000-00030","volume":"21","author":"D Rizzoni","year":"2003","unstructured":"Rizzoni D, Palombo C, Porteri E, et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens. 2003;21(3):625\u201331.","journal-title":"J Hypertens"},{"issue":"7","key":"1116_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/diab.42.7.1017","volume":"42","author":"A Nitenberg","year":"1993","unstructured":"Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 1993;42(7):1017\u201325.","journal-title":"Diabetes"},{"issue":"6","key":"1116_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2265.2004.02156.x","volume":"61","author":"N Dagres","year":"2004","unstructured":"Dagres N, Saller B, Haude M, et al. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf). 2004;61(6):724\u201331.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1116_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0735-1097(00)00697-5","volume":"36","author":"PA Kaufmann","year":"2000","unstructured":"Kaufmann PA, Gnecchi-Ruscone T, Sch\u00e4fers KP, L\u00fcscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol. 2000;36(1):103\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1116_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.ki.5000031","volume":"69","author":"AR Chade","year":"2006","unstructured":"Chade AR, Brosh D, Higano ST, Lennon RJ, Lerman LO, Lerman A. Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease. Kidney Int. 2006;69(2):266\u201371.","journal-title":"Kidney Int"},{"issue":"4","key":"1116_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1536\/ihj.50.407","volume":"50","author":"SA Sakr","year":"2009","unstructured":"Sakr SA, Abbas TM, Amer MZ, et al. Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J. 2009;50(4):407\u201319.","journal-title":"Int Heart J"},{"issue":"9","key":"1116_CR33","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/S0735-1097(03)00243-2","volume":"41","author":"J Cos\u00edn-Sales","year":"2003","unstructured":"Cos\u00edn-Sales J, Pizzi C, Brown S, Kaski JC. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol. 2003;41(9):1468\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1116_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s12350-020-02166-5","volume":"29","author":"B Weber","year":"2022","unstructured":"Weber B, Perez-Chada LM, Divakaran S, et al. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2022;29(1):37\u201342.","journal-title":"J Nucl Cardiol"},{"key":"1116_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2016.05.036","volume":"251","author":"S Piaserico","year":"2016","unstructured":"Piaserico S, Osto E, Famoso G, et al. Treatment with tumor necrosis factor inhibitors restores coronary microvascular function in young patients with severe psoriasis. Atherosclerosis. 2016;251:25\u201330.","journal-title":"Atherosclerosis"},{"issue":"9","key":"1116_CR36","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135\u201343.","journal-title":"Circulation"},{"key":"1116_CR37","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhang X, Lu S, Chuankai Z, Zhe M, Rui S, et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat Cardiovasc Res. 2023;2(3):290-306. https:\/\/doi.org\/10.1038\/s44161-023-00218-w","DOI":"10.1038\/s44161-023-00218-w"},{"issue":"3","key":"1116_CR38","doi-asserted-by":"publisher","first-page":"e003064","DOI":"10.1161\/JAHA.115.003064","volume":"5","author":"ND Mygind","year":"2016","unstructured":"Mygind ND, Michelsen MM, Pena A, et al. Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study. J Am Heart Assoc. 2016;5(3):e003064.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1116_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/clc.19","volume":"30","author":"TR Wessel","year":"2007","unstructured":"Wessel TR, Arant CB, McGorray SP, et al. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women\u2019s Ischemia Syndrome Evaluation (WISE). Clin Cardiol. 2007;30(2):69\u201374.","journal-title":"Clin Cardiol"},{"issue":"24","key":"1116_CR40","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","volume":"129","author":"VL Murthy","year":"2014","unstructured":"Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129(24):2518\u201327.","journal-title":"Circulation"},{"key":"1116_CR41","doi-asserted-by":"publisher","unstructured":"Vink CEM, Hoef TP, Lee JM, et al. The ILIAS Registry Investigators , Sex-differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome \u2013 analysis from the multi-center international ILIAS Registry, European Heart Journal. 2022;43(Supplement_2):ehac544-1152. https:\/\/doi.org\/10.1093\/eurheartj\/ehac544.1152","DOI":"10.1093\/eurheartj\/ehac544.1152"},{"issue":"6","key":"1116_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.023266","volume":"135","author":"VR Taqueti","year":"2017","unstructured":"Taqueti VR, Shaw LJ, Cook NR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation. 2017;135(6):566\u201377. Confirmed prior data that women have a lower rate of obstructive CAD but an equivalent rate of adverse cardiovascular outcomes, and demonstrated that this risk in women was closely tied to impaired coronary flow reserve, as measured by PET.","journal-title":"Circulation"},{"issue":"25","key":"1116_CR43","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","volume":"55","author":"CJ Pepine","year":"2010","unstructured":"Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55(25):2825\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1116_CR44","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67\u2013492.","journal-title":"Circulation"},{"issue":"4","key":"1116_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tsch\u00f6pe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"1116_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","volume":"39","author":"VR Taqueti","year":"2017","unstructured":"Taqueti VR, Solomon SD, Shah AM, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2017;39(10):840\u20139.","journal-title":"Eur Heart J"},{"issue":"9","key":"1116_CR47","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","volume":"169","author":"M Gulati","year":"2009","unstructured":"Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women\u2019s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843\u201350.","journal-title":"Arch Intern Med"},{"issue":"24","key":"1116_CR48","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.jacc.2021.10.009","volume":"78","author":"J-M Ahn","year":"2021","unstructured":"Ahn J-M, Zimmermann FM, Gullestad L, et al. Microcirculatory resistance predicts allograft rejection and cardiac events after heart transplantation. J Am Coll Cardiol. 2021;78(24):2425\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1116_CR49","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/eurheartj\/ehq039","volume":"31","author":"L Galiuto","year":"2010","unstructured":"Galiuto L, De Caterina AR, Porfidia A, et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome. Eur Heart J. 2010;31(11):1319\u201327.","journal-title":"Eur Heart J"},{"issue":"6","key":"1116_CR50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jamacardio.2016.5993","volume":"2","author":"F Rivero","year":"2017","unstructured":"Rivero F, Cuesta J, Garc\u00eda-Guimaraes M, et al. Time-related microcirculatory dysfunction in patients with Takotsubo cardiomyopathy. JAMA Cardiology. 2017;2(6):699\u2013700.","journal-title":"JAMA Cardiology"},{"issue":"15","key":"1116_CR51","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395\u2013407.","journal-title":"N Engl J Med"},{"issue":"10115","key":"1116_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","volume":"391","author":"R Al-Lamee","year":"2018","unstructured":"Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31\u201340.","journal-title":"Lancet"},{"issue":"24","key":"1116_CR53","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1161\/CIRCULATIONAHA.112.001345","volume":"128","author":"M Echavarria-Pinto","year":"2013","unstructured":"Echavarria-Pinto M, Escaned J, Mac\u00edas E, et al. Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation. 2013;128(24):2557\u201366.","journal-title":"Circulation"},{"key":"1116_CR54","doi-asserted-by":"publisher","unstructured":"Bulluck H, Foin N, Tan JW, et al. Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand? Circulation: Cardiovascular Interventions. 2017;10(3):e004373.\u00a0https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004373","DOI":"10.1161\/CIRCINTERVENTIONS.116.004373"},{"issue":"9","key":"1116_CR55","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","volume":"7","author":"M van Kranenburg","year":"2014","unstructured":"van Kranenburg M, Magro M, Thiele H, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014;7(9):930\u20139.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1116_CR56","doi-asserted-by":"publisher","unstructured":"De Gaspari M, Basso C, Perazzolo Marra M, et al. Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis. Journal of Clinical Medicine. 2021;10(4):575. https:\/\/doi.org\/10.3390\/jcm10040575","DOI":"10.3390\/jcm10040575"},{"issue":"9","key":"1116_CR57","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Olivotto I, Maron BJ, et al. the case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54(9):866\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1116_CR58","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","volume":"2","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Bruyere J Jr, et al. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014;2(4):358\u201367.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"1116_CR59","first-page":"e009104","volume":"12","author":"F Graziani","year":"2019","unstructured":"Graziani F, Lillo R, Panaioli E, et al. Massive coronary microvascular dysfunction in severe Anderson-Fabry disease cardiomyopathy. Circulation: Cardiov Imaging. 2019;12(6):e009104.","journal-title":"Circulation: Cardiov Imaging"},{"issue":"8","key":"1116_CR60","first-page":"e007547","volume":"12","author":"HZR McConkey","year":"2019","unstructured":"McConkey HZR, Marber M, Chiribiri A, Pibarot P, Redwood SR, Prendergast BD. Coronary microcirculation in aortic stenosis. Circulation: Cardiovasc Interv. 2019;12(8):e007547.","journal-title":"Circulation: Cardiovasc Interv"},{"issue":"8 Pt 2","key":"1116_CR61","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcmg.2018.10.032","volume":"12","author":"A Gulati","year":"2019","unstructured":"Gulati A, Ismail TF, Ali A, et al. Microvascular dysfunction in dilated cardiomyopathy: a quantitative stress perfusion cardiovascular magnetic resonance study. JACC Cardiovasc Imaging. 2019;12(8 Pt 2):1699\u2013708.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"22","key":"1116_CR62","first-page":"e368","volume":"144","author":"M Gulati","year":"2021","unstructured":"Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368\u2013454.","journal-title":"Circulation"},{"issue":"3","key":"1116_CR63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2019","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes: the task force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2019;41(3):407\u201377.","journal-title":"Eur Heart J"},{"issue":"17","key":"1116_CR64","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.105.603522","volume":"113","author":"MKC Ng","year":"2006","unstructured":"Ng MKC, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation. Circulation. 2006;113(17):2054\u201361.","journal-title":"Circulation"},{"issue":"12","key":"1116_CR65","doi-asserted-by":"publisher","first-page":"e005361","DOI":"10.1161\/CIRCINTERVENTIONS.117.005361","volume":"10","author":"WF Fearon","year":"2017","unstructured":"Fearon WF, Kobayashi Y. Invasive assessment of the coronary microvasculature. Circulation Cardiov Interv. 2017;10(12):e005361.","journal-title":"Circulation Cardiov Interv"},{"key":"1116_CR66","doi-asserted-by":"publisher","unstructured":"Gallinoro E, Bertolone DT, Fernandez-Peregrina E, et al. Reproducibility of bolus versus continuous thermodilution for assessment of coronary microvascular function in patients with ANOCA. EuroIntervention. 2023;19(2):e155-e166. https:\/\/doi.org\/10.4244\/EIJ-D-22-00772","DOI":"10.4244\/EIJ-D-22-00772"},{"issue":"6","key":"1116_CR67","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jcin.2012.01.023","volume":"5","author":"J Wei","year":"2012","unstructured":"Wei J, Mehta PK, Johnson BD, et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women\u2019s Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv. 2012;5(6):646\u201353.","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"1116_CR68","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.jacc.2022.03.385","volume":"79","author":"T Takahashi","year":"2022","unstructured":"Takahashi T, Samuels BA, Li W, et al. Safety of provocative testing with intracoronary acetylcholine and implications for standard protocols. J Am Coll Cardiol. 2022;79(24):2367\u201378.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1116_CR69","doi-asserted-by":"publisher","first-page":"e023207","DOI":"10.1161\/JAHA.121.023207","volume":"11","author":"N Mileva","year":"2022","unstructured":"Mileva N, Nagumo S, Mizukami T, et al. Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis. J Am Heart Assoc. 2022;11(7):e023207.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"1116_CR70","doi-asserted-by":"publisher","first-page":"e012017","DOI":"10.1161\/CIRCINTERVENTIONS.122.012017","volume":"15","author":"RGT Feenstra","year":"2022","unstructured":"Feenstra RGT, Boerhout CKM, Woudstra J, et al. Presence of coronary endothelial dysfunction, coronary vasospasm, and adenosine-mediated vasodilatory disorders in patients with ischemia and nonobstructive coronary arteries. Circ Cardiovasc Interv. 2022;15(8):e012017. Among patients with INOCA without inducible coronary artery spasm and with normal adenosine-mediated vasodilation, two-thirds had endothelial dysfunction, providing therapeutic implication.","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"1116_CR71","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2967\/jnumed.117.201368","volume":"59","author":"VL Murthy","year":"2018","unstructured":"Murthy VL, Bateman TM, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Med. 2018;59(2):273\u201393.","journal-title":"J Nucl Med"},{"issue":"8","key":"1116_CR72","first-page":"e006427","volume":"10","author":"A Feher","year":"2017","unstructured":"Feher A, Sinusas AJ. Quantitative assessment of coronary microvascular function. Circulation: Cardiovasc Imaging. 2017;10(8):e006427.","journal-title":"Circulation: Cardiovasc Imaging"},{"issue":"10","key":"1116_CR73","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jcmg.2018.12.022","volume":"12","author":"T Kotecha","year":"2019","unstructured":"Kotecha T, Martinez-Naharro A, Boldrini M, et al. Automated pixel-wise quantitative myocardial perfusion mapping by CMR to detect obstructive coronary artery disease and coronary microvascular dysfunction: validation against invasive coronary physiology. JACC Cardiovasc Imaging. 2019;12(10):1958\u201369.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1116_CR74","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12968-018-0435-1","volume":"20","author":"B Zorach","year":"2018","unstructured":"Zorach B, Shaw PW, Bourque J, et al. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. J Cardiovasc Magn Reson. 2018;20(1):14.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1116_CR75","doi-asserted-by":"publisher","unstructured":"Thomson LE, Wei J, Agarwal M, et al. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging. 201;8(4)e002481. https:\/\/doi.org\/10.1161\/CIRCIMAGING.114.002481","DOI":"10.1161\/CIRCIMAGING.114.002481"},{"issue":"5","key":"1116_CR76","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0735-1097(98)00389-1","volume":"32","author":"T Hozumi","year":"1998","unstructured":"Hozumi T, Yoshida K, Akasaka T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol. 1998;32(5):1251\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1116_CR77","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1365-2281.2001.00296.x","volume":"21","author":"M Saraste","year":"2001","unstructured":"Saraste M, Koskenvuo J, Knuuti J, et al. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol. 2001;21(1):114\u201322.","journal-title":"Clin Physiol"},{"key":"1116_CR78","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijcard.2016.11.004","volume":"228","author":"MM Michelsen","year":"2017","unstructured":"Michelsen MM, Mygind ND, Pena A, et al. Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: the iPOWER study. Int J Cardiol. 2017;228:435\u201343.","journal-title":"Int J Cardiol"},{"issue":"22","key":"1116_CR79","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/S0195-668X(03)00478-0","volume":"24","author":"M Kayikcioglu","year":"2003","unstructured":"Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J. 2003;24(22):1999\u20132005.","journal-title":"Eur Heart J"},{"issue":"3","key":"1116_CR80","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.ATV.20.3.737","volume":"20","author":"S Hamasaki","year":"2000","unstructured":"Hamasaki S, Higano ST, Suwaidi JA, et al. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol. 2000;20(3):737\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1116_CR81","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0002-9149(02)02664-4","volume":"90","author":"J-W Chen","year":"2002","unstructured":"Chen J-W, Hsu N-W, Wu T-C, Lin S-J, Chang M-S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol. 2002;90(9):974\u201382.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1116_CR82","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"DF Pauly","year":"2011","unstructured":"Pauly DF, Johnson BD, Anderson RD, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women\u2019s Ischemia Syndrome Evaluation (WISE). Am Heart J. 2011;162(4):678\u201384.","journal-title":"Am Heart J"},{"issue":"4","key":"1116_CR83","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0735-1097(02)02033-8","volume":"40","author":"OO Akinboboye","year":"2002","unstructured":"Akinboboye OO, Chou RL, Bergmann SR. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. J Am Coll Cardiol. 2002;40(4):703\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1116_CR84","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/10739680701410827","volume":"14","author":"T Higuchi","year":"2007","unstructured":"Higuchi T, Abletshauser C, Nekolla SG, Schwaiger M, Bengel FM. Effect of the angiotensin receptor blocker valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease. Microcirculation. 2007;14(8):805\u201312.","journal-title":"Microcirculation"},{"issue":"3","key":"1116_CR85","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1751-7176.2010.00401.x","volume":"13","author":"H Lethen","year":"2011","unstructured":"Lethen H, Tries HP, Kersting S, Bramlage P, Lambertz H. Improvement of coronary microvascular function after angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension. J Clin Hypertens (Greenwich). 2011;13(3):155\u201361.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1116_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ahj.2021.03.011","volume":"237","author":"EM Handberg","year":"2021","unstructured":"Handberg EM, Merz CNB, Cooper-Dehoff RM, et al. Rationale and design of the Women\u2019s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) Trial. Am Heart J. 2021;237:90\u2013103. The WARRIOR trial will be the first large trial to examine the impact of intensive medical therapy on intermediate-term cardiovascular in women with anginal signs\/symptoms with no obstructive epicardial coronary artery disease, and will provide crucial information to inform future guidelines.","journal-title":"Am Heart J"},{"issue":"2","key":"1116_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10557-006-0494-7","volume":"21","author":"M Togni","year":"2007","unstructured":"Togni M, Vigorito F, Windecker S, et al. Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther. 2007;21(2):99\u2013108.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"1116_CR88","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0002-9149(89)90332-9","volume":"63","author":"R Bugiardini","year":"1989","unstructured":"Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol. 1989;63(5):286\u201390.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1116_CR89","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","volume":"116","author":"CN Bairey Merz","year":"2020","unstructured":"Bairey Merz CN, Pepine CJ, Shimokawa H, Berry C. Treatment of coronary microvascular dysfunction. Cardiovasc Res. 2020;116(4):856\u201370.","journal-title":"Cardiovasc Res"},{"issue":"23 Pt A","key":"1116_CR90","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","volume":"72","author":"TJ Ford","year":"2018","unstructured":"Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol. 2018;72(23 Pt A):2841\u201355. The CorMicA trial is a randomized trial that demonstrated a benefit in term of symptoms at 6 months of stratified medical therapy guided by invasive coronary function testing compared with sham control.","journal-title":"J Am Coll Cardiol"},{"key":"1116_CR91","doi-asserted-by":"publisher","unstructured":"Jansen TPJ, Konst RE, de Vos A, et al. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial. JACC Cardiovascular Imaging. 2022;15(8):1473-1484. https:\/\/doi.org\/10.1016\/j.jcmg.2022.03.012","DOI":"10.1016\/j.jcmg.2022.03.012"},{"issue":"1","key":"1116_CR92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cjco.2020.09.005","volume":"3","author":"T Kofler","year":"2020","unstructured":"Kofler T, Hess S, Moccetti F, et al. Efficacy of ranolazine for treatment of coronary microvascular dysfunction-a systematic review and meta-analysis of randomized trials. CJC Open. 2020;3(1):101\u20138.","journal-title":"CJC Open"},{"issue":"19","key":"1116_CR93","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","volume":"37","author":"CN Bairey Merz","year":"2015","unstructured":"Bairey Merz CN, Handberg EM, Shufelt CL, et al. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J. 2015;37(19):1504\u201313.","journal-title":"Eur Heart J"},{"issue":"10","key":"1116_CR94","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.clinthera.2019.08.008","volume":"41","author":"H Zhu","year":"2019","unstructured":"Zhu H, Xu X, Fang X, et al. Effects of the antianginal drugs ranolazine, nicorandil, and ivabradine on coronary microvascular function in patients with nonobstructive coronary artery disease: a meta-analysis of randomized controlled trials. Clin Ther. 2019;41(10):2137-2152.e2112.","journal-title":"Clin Ther"},{"key":"1116_CR95","doi-asserted-by":"publisher","unstructured":"Leonova IA, Boldueva S, Zakharova O, et al. Trimetazidine improves symptoms and reduces microvascular dysfunction in patients with microvascular angina, European Heart Journal. 2017;38(suppl_1).ehx501.P887. https:\/\/doi.org\/10.1093\/eurheartj\/ehx501.P887","DOI":"10.1093\/eurheartj\/ehx501.P887"},{"issue":"8","key":"1116_CR96","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/clc.20935","volume":"34","author":"SJ Denardo","year":"2011","unstructured":"Denardo SJ, Wen X, Handberg EM, et al. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women\u2019s Ischemia Syndrome Evaluation (WISE) ancillary study. Clin Cardiol. 2011;34(8):483\u20137.","journal-title":"Clin Cardiol"},{"key":"1116_CR97","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2015.03.118","volume":"185","author":"RH Olsen","year":"2015","unstructured":"Olsen RH, Pedersen LR, J\u00fcrs A, Snoer M, Haugaard SB, Prescott E. A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease. Int J Cardiol. 2015;185:229\u201335.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1116_CR98","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.atherosclerosis.2011.01.012","volume":"215","author":"C Rooks","year":"2011","unstructured":"Rooks C, Faber T, Votaw J, et al. Effects of smoking on coronary microcirculatory function: a twin study. Atherosclerosis. 2011;215(2):500\u20136.","journal-title":"Atherosclerosis"},{"issue":"2","key":"1116_CR99","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ijcard.2008.03.022","volume":"135","author":"KD Kronhaus","year":"2009","unstructured":"Kronhaus KD, Lawson WE. Enhanced external counterpulsation is an effective treatment for syndrome X. Int J Cardiol. 2009;135(2):256\u20137.","journal-title":"Int J Cardiol"},{"issue":"9","key":"1116_CR100","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/clc.20140","volume":"30","author":"M Caliskan","year":"2007","unstructured":"Caliskan M, Erdogan D, Gullu H, et al. Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol. 2007;30(9):475\u20139.","journal-title":"Clin Cardiol"},{"issue":"7","key":"1116_CR101","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/hrt.2006.095208","volume":"93","author":"D Neglia","year":"2007","unstructured":"Neglia D, De Maria R, Masi S, et al. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart. 2007;93(7):808\u201313.","journal-title":"Heart"},{"issue":"7","key":"1116_CR102","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0002-9149(99)00450-6","volume":"84","author":"GA Lanza","year":"1999","unstructured":"Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. 1999;84(7):854\u20136.","journal-title":"Am J Cardiol"},{"issue":"4","key":"1116_CR103","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","volume":"56","author":"RO Cannon 3rd","year":"1985","unstructured":"Cannon RO 3rd, Watson RM, Rosing DR, Epstein SE. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol. 1985;56(4):242\u20136.","journal-title":"Am J Cardiol"},{"key":"1116_CR104","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2018.09.081","volume":"276","author":"CA Rambarat","year":"2019","unstructured":"Rambarat CA, Elgendy IY, Handberg EM, et al. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women\u2019s Ischemia Syndrome Evaluation\u2013 coronary vascular dysfunction ancillary study. Int J Cardiol. 2019;276:8\u201313.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1116_CR105","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","volume":"112","author":"A Villano","year":"2013","unstructured":"Villano A, Di Franco A, Nerla R, et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol. 2013;112(1):8\u201313.","journal-title":"Am J Cardiol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-023-01116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-023-01116-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-023-01116-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T11:24:58Z","timestamp":1691580298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-023-01116-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1007\/s11883-023-01116-z","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"1 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to present the correct alignment of the first column entries in Table 1.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Janet Wei served on an advisory board for Abbott Vascular. C. Noel Bairey Merz serves as Board of Director for iRhythm, fees paid through CSMC from Abbott Diagnostics and Sanofi, and consulting for SHL Telemedicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any previously unpublished studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}